Skip to content

Use of Proteomics for the Diagnosis of a Platelet-related Bleeding Disorder

Use of Proteomics for the Diagnosis of a Platelet-related Bleeding Disorder

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02096523
Enrollment
4
Registered
2014-03-26
Start date
2016-11-30
Completion date
2021-07-31
Last updated
2021-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inherited Platelet Disorders

Keywords

inherited platelet disorders, proteome

Brief summary

The goal of this study is to identify the platelet defect responsible for the bleeding in families from our inherited platelet disorders Israeli-Palestinian registry. The investigators plan to characterize platelet proteome expression after removing high abundance proteins. The investigators will compare the proteome of sick and healthy members of families with inherited platelet disorders, and identify and validate structural proteins, signaling cascades and biomarkers for detection and diagnosis of unknown platelet disorders. The investigators expect to discover new key findings that allow better understanding of human platelet function and allow better diagnosis and treatment of patients with inherited platelet function disorders.

Interventions

OTHERBlood collection for platelet protein samples

Sponsors

Ela Shai
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
3 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

* History of inherited platelet disorders in the family

Exclusion criteria

* none

Design outcomes

Primary

MeasureTime frameDescription
Levels of detectable platelet proteins2014-2015 (1 year)Characterize platelet proteome expression profile

Secondary

MeasureTime frameDescription
Changes in protein expression from sick and healthy platelets2015-2019 (4 years)Analysis of platelet proteome of sick and healthy members of families with inherited platelet disorders

Other

MeasureTime frameDescription
Number of proteins that inducate disease2017-2019 (2 years)Identify and validate a panel of specific biomarkers candidates

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026